[Prognostic factors in plasmocytoma (author's transl)]

Surgical results in patients with CNS lymphoma. Comparison of predictive value of intraoperative MRI and intraoperative histological examination for diagnostic biopsy yield.

Brain & spine·2024

Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.

American journal of hematology·2023

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL).

Annals of hematology·2022

PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population.

Folia biologica·2021

Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma.

Folia biologica·2020

Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.

Annals of hematology·2017

[Tenth memorial of professor Frantisek Pór, MD].

Sbornik lekarsky·2004

[A brief overview of the history of the Institute of Human Studies in Medicine at the First Medical Faculty of Charles University in Prague].

Sbornik lekarsky·2004

[The strategy and contemporary subjects of research in psychotherapy].

Sbornik lekarsky·2004

[General psychotherapy].

Sbornik lekarsky·2004

[Microsleep from the electro- and psychophysiological point of view].

Sbornik lekarsky·2004

[Bartter syndrome or renal tubular acidosis?].

Sbornik lekarsky·2004

Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis.

Archives of Iranian medicine·2026

Assessement of Survival and its Affecting Factors in Adult Liver Transplant Patients: A Retrospective Cohort Study.

Archives of Iranian medicine·2026

Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma.

Journal of inflammation research·2026

Cumulative high-risk surgical and pathologic features predict recurrence after resection of early-stage node-negative non-small cell lung cancer.

JTCVS open·2026

Reassessing delayed chest closure in lung transplantation: Outcomes from a propensity score-matched cohort.

JTCVS open·2026

Increasing time-to-treatment for resectable non-small cell lung cancer: Predictors and survival impact.

JTCVS open·2026

Related Experiment Videos

[Prognostic factors in plasmocytoma (author's transl)]

Related Concept Videos

Surgical results in patients with CNS lymphoma. Comparison of predictive value of intraoperative MRI and intraoperative histological examination for diagnostic biopsy yield.

Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL).

PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population.

Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma.

Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.

[Tenth memorial of professor Frantisek Pór, MD].

[A brief overview of the history of the Institute of Human Studies in Medicine at the First Medical Faculty of Charles University in Prague].

[The strategy and contemporary subjects of research in psychotherapy].

[General psychotherapy].

[Microsleep from the electro- and psychophysiological point of view].

[Bartter syndrome or renal tubular acidosis?].

Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis.

Assessement of Survival and its Affecting Factors in Adult Liver Transplant Patients: A Retrospective Cohort Study.

Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma.

Cumulative high-risk surgical and pathologic features predict recurrence after resection of early-stage node-negative non-small cell lung cancer.

Reassessing delayed chest closure in lung transplantation: Outcomes from a propensity score-matched cohort.

Increasing time-to-treatment for resectable non-small cell lung cancer: Predictors and survival impact.

Related Experiment Videos

[Prognostic factors in plasmocytoma (author's transl)]

Related Concept Videos

Related Articles